Literature DB >> 18203200

Sequence variation in the ATP-binding domain of the Wilson disease transporter, ATP7B, affects copper transport in a yeast model system.

Gloria Hsi1, Lara M Cullen, Georgina Macintyre, Matthew M Chen, D Moira Glerum, Diane W Cox.   

Abstract

ATP7B is a copper transporting P-type ATPase defective in the autosomal recessive copper storage disorder, Wilson disease (WND). Functional assessment of variants helps to distinguish normal from disease-causing variants and provides information on important amino acid residues. A total of 11 missense variants of ATP7B, originally identified in WND patients, were examined for their capacity to functionally complement a yeast mutant strain in which the yeast gene ortholog, CCC2, was disrupted. Solution structures of ATP7B domains were used to predict the effects of each variant on ATP7B structure. Three variants lie within the copper-binding domain and eight within the ATP-binding domain of ATP7B. All three ATP7B variants within the copper-binding domain and four within the ATP-binding domain showed full complementation of the yeast ccc2 phenotype. For the remaining four located in the ATP-binding domain, p.Glu1064Lys and p.Val1106Asp were unable to complement the yeast ccc2 high-affinity iron uptake deficiency phenotype, apparently due to mislocalization and/or change in conformation of the variant protein. p.Leu1083Phe exhibited a temperature-sensitive phenotype with partial complementation at 30 degrees C and a severe deficit at 37 degrees C. p.Met1169Val only partially complemented the ccc2 phenotype at 30 degrees C and 37 degrees C. Therefore, four variant positions were identified as important for copper transport and as disease-causing changes. Since the yeast assay specifically evaluates copper transport function, variants with normal transport could be defective in some other aspect of ATP7B function, particularly trafficking in mammalian cells. Functional assessment is critical for reliable use of mutation analysis as an aid to diagnosis of this clinically variable condition. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18203200     DOI: 10.1002/humu.20674

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

Review 1.  ATP7A-related copper transport diseases-emerging concepts and future trends.

Authors:  Stephen G Kaler
Journal:  Nat Rev Neurol       Date:  2011-01       Impact factor: 42.937

2.  Role of external loops of human ceruloplasmin in copper loading by ATP7B and Ccc2p.

Authors:  Nunziata Maio; Fabio Polticelli; Giovanni De Francesco; Gianluca Rizzo; Maria Carmela Bonaccorsi di Patti; Giovanni Musci
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

3.  Diverse functional properties of Wilson disease ATP7B variants.

Authors:  Dominik Huster; Angelika Kühne; Ashima Bhattacharjee; Lily Raines; Vanessa Jantsch; Johannes Noe; Wiebke Schirrmeister; Ines Sommerer; Osama Sabri; Frieder Berr; Joachim Mössner; Bruno Stieger; Karel Caca; Svetlana Lutsenko
Journal:  Gastroenterology       Date:  2012-01-10       Impact factor: 22.682

4.  A structural model of the copper ATPase ATP7B to facilitate analysis of Wilson disease-causing mutations and studies of the transport mechanism.

Authors:  Maya Schushan; Ashima Bhattacharjee; Nir Ben-Tal; Svetlana Lutsenko
Journal:  Metallomics       Date:  2012-06-13       Impact factor: 4.526

5.  Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B.

Authors:  Lelita T Braiterman; Amrutha Murthy; Samuel Jayakanthan; Lydia Nyasae; Eric Tzeng; Grazyna Gromadzka; Thomas B Woolf; Svetlana Lutsenko; Ann L Hubbard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

6.  Elucidation of the ATP7B N-domain Mg2+-ATP coordination site and its allosteric regulation.

Authors:  Claude Hercend; Cyril Bauvais; Guillaume Bollot; Nicolas Delacotte; Philippe Chappuis; France Woimant; Jean-Marie Launay; Philippe Manivet
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

7.  Disease-causing point-mutations in metal-binding domains of Wilson disease protein decrease stability and increase structural dynamics.

Authors:  Ranjeet Kumar; Candan Ariöz; Yaozong Li; Niklas Bosaeus; Sandra Rocha; Pernilla Wittung-Stafshede
Journal:  Biometals       Date:  2016-10-15       Impact factor: 2.949

Review 8.  The six metal binding domains in human copper transporter, ATP7B: molecular biophysics and disease-causing mutations.

Authors:  Candan Ariöz; Yaozong Li; Pernilla Wittung-Stafshede
Journal:  Biometals       Date:  2017-10-23       Impact factor: 2.949

9.  Advance in the pathogenesis and treatment of Wilson disease.

Authors:  Qin-Yun Dong; Zhi-Ying Wu
Journal:  Transl Neurodegener       Date:  2012-11-27       Impact factor: 8.014

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.